Novartis AG (NVSEF)
OTCMKTS
· Delayed Price · Currency is USD
111.41
+0.06 (0.05%)
Apr 24, 2025, 10:32 AM EDT
Novartis AG Revenue
In the year 2024, Novartis AG had annual revenue of $51.72B with 10.85% growth. Novartis AG had revenue of $13.56B in the quarter ending December 31, 2024, with 15.13% growth.
Revenue
51.72B
Revenue Growth
+10.85%
P/S Ratio
4.08
Revenue / Employee
681.60K
Employees
75,883
Market Cap
210.89B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 51.72B | 5.06B | 10.85% |
Dec 31, 2023 | 46.66B | 3.20B | 7.36% |
Dec 31, 2022 | 43.46B | -513.00M | -1.17% |
Dec 31, 2021 | 43.97B | -5.92B | -11.87% |
Dec 31, 2020 | 49.90B | 1.22B | 2.51% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
SS Innovations International | 20.65M |
Endo Inc. | 1.76B |
Veradigm | 588.02M |
Northwest Biotherapeutics | 1.38M |
Elite Pharmaceuticals | 70.00M |
Glass House Brands | 200.90M |
BioStem Technologies | 301.83M |
American Oncology Network | 1.76B |
Novartis AG News
- 1 day ago - Novartis and Sanofi CEOs say EU should raise drug prices in face of tariffs - Reuters
- 2 days ago - Swiss pharma giant Roche to invest $50 billion in US amid growing tariff uncertainty - The Times of India
- 3 days ago - LLY, NVO and AMGN Forecast – Pharma Stocks to Open Mixed - FXEmpire
- 7 days ago - Alembic Pharmaceuticals gets USFDA final approval for Carbamazepine tablets USP 200 mg - Business Upturn
- 7 days ago - EWL: A More Political Stable, But Too Expensive Alternative To The U.S. - Seeking Alpha
- 10 days ago - Trump says US pharma tariffs coming in not-too-distant future - Reuters
- 12 days ago - Inflation Might Be Easing But Tech Outlook Still Choppy, Analysts Warn - Benzinga
- 13 days ago - Trump's pharmaceutical tariffs could raise costs for patients, worsen drug shortages - CNBC